A phase I dose escalation study of intra-tumoral LTX-315 as monotherapy or in combination with either ipilimumab or pembrolizumab in patients with transdermally accessible tumors (NCT01986426) — J.F. Baurain (2017) | RDL Network
A phase I dose escalation study of intra-tumoral LTX-315 as monotherapy or in combination with either ipilimumab or pembrolizumab in patients with transdermally accessible tumors (NCT01986426)
Aaron R. Hansen, Jeffrey R. Infante, Grant A. McArthur, Michael S. Gordon, Alexander M. Lesokhin, Ann-Lee Stayner, Todd M. Bauer, Shahneen Sandhu, Frank Tsai, Alexandra Snyder, Deepa S. Subramaniam, Jeong Kim, Eric Stefanich, Chi‐Chung Li, Jane Ruppel, Maria Anderson, Houston Gilbert, Bruce McCall, Mahrukh Huseni, Ina Rhee, Michael J. Pishvaian
Jayesh Desai, Ben Markman, Shahneen Sandhu, Hui Gan, Michael Friedlander, Ben Tran, Tarek Meniawy, Vishal Boolell, Duncan Colyer, Christie Norris, Malaka Ameratunga, Jason Yang, Kang Li, Lai Wang, Lusong Luo, Zhen Qin, Michael Millward
Jeffrey R. Infante, Aaron R. Hansen, Michael J. Pishvaian, Laura Q.M. Chow, Grant A. McArthur, Todd M. Bauer, Stephen V. Liu, Shahneen Sandhu, Frank Tsai, Jeong Kim, Eric Stefanich, Chi‐Chung Li, Houston Gilbert, Bruce McCall, Maria Anderson, Mahrukh Huseni, Ina Rhee, Lillian L. Siu, Michael S. Gordon
Reinhard Dummer, Georgina V. Long, Anna C. Pavlick, Michael A. Postow, Antoni Ribas, Caroline Robert, Richard A Scolyer, Janis M. Taube, Michael T. Tetzlaff, Jason J. Z. Liao, Sama Ahsan, Scott J. Diede, Hussein A. Tawbi
Amit Khot, Natalie Brajanovski, Donald P. Cameron, Nadine Hein, Kylee Maclachlan, Elaine Sanij, John K. C. Lim, John Soong, Emma Link, Piers Blombery, Ella R. Thompson, Andrew Fellowes, Karen E. Sheppard, Grant A. McArthur, Richard B. Pearson, Ross D. Hannan, Gretchen Poortinga, Simon J. Harrison
Discussion(0)
No comments yet. Be the first to comment.